PLAN B Drug Patent Profile
✉ Email this page to a colleague
When do Plan B patents expire, and what generic alternatives are available?
Plan B is a drug marketed by Fdn Consumer and is included in two NDAs.
The generic ingredient in PLAN B is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Plan B
A generic version of PLAN B was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PLAN B?
- What are the global sales for PLAN B?
- What is Average Wholesale Price for PLAN B?
Summary for PLAN B
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 3,678 |
What excipients (inactive ingredients) are in PLAN B? | PLAN B excipients list |
DailyMed Link: | PLAN B at DailyMed |
US Patents and Regulatory Information for PLAN B
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fdn Consumer | PLAN B | levonorgestrel | TABLET;ORAL | 021045-001 | Jul 28, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fdn Consumer | PLAN B | levonorgestrel | TABLET;ORAL | 021045-002 | Aug 24, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fdn Consumer | PLAN B ONE-STEP | levonorgestrel | TABLET;ORAL | 021998-001 | Jul 10, 2009 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |